At 20 years, the average concentration of GHK-Cu of 200 ng/mL declines to 80 ng/mL by 60 years
Hochrein SM, Wu H, Eckstein M, Arrigoni L, Herman JS, Schumacher F, et al
Glutathione, Cysteine, and the Neuromelanin Pathway: Potential Roles in the Pathogenesis of Parkinson's Disease - a New Hypothesis Glenn Dryhurst 16
DelveInsights GLP-1 Agonists Market Insights report includes a comprehensive understanding of current treatment practices, emerging GLP-1 agonists, market share of individual therapies, and current and forecasted GLP-1 agonists market size from 2020 to 2034, segmented into 7MM [the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan]
doi:10.1016/j.lfs.2004.03.024 34